UK medicines regulator says new laws are needed as AI becomes routine in the NHS

Started by Annie, Sep 10, 2026, 07:52 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

Topic: UK medicines regulator says new laws are needed as AI becomes routine in the NHS   Views(Read 126 times)

Annie

The Medicines and Healthcare products Regulatory Agency published 44 recommendations to update UK policy as AI use grows across the NHS and wider healthcare sector, with MHRA chief Lawrence Tallon telling the BBC that patients will increasingly see AI as part of how normal NHS healthcare gets delivered. The report was compiled by an independent commission drawing on input from more than 12,000 people, including both patients and clinicians

Tallon said the existing medical devices regulatory framework predominantly dates from an era focused on things like hip replacements, knee replacements, stethoscopes and plasters, and while current guidelines can work for simpler AI products trained to spot known symptoms on scans, they don't adequately cover more complex, adaptive models. Unlike most medical products regulators are used to overseeing, he said, these AI systems keep changing after they've already been authorized, since as new data gets fed in, they learn, adapt and drift over time

Key recommendations include continuously monitoring AI products and pulling regulatory approval if they malfunction or become less effective, giving patients an explicit right to know when AI is involved in their care along with easy access to information about the specific products used, granting regulators power to penalize developers whose products fail to meet required standards, and creating an AI L-plate system letting new models be trialed by healthcare professionals under close supervision. Tallon acknowledged regulating AI is a genuinely global challenge, saying he can't point to any single country or regulatory framework that's fully cracked it yet. Curious what people think about this specific L-plate concept, does supervised trialing under close professional oversight strike the right balance between innovation and patient safety, or does it risk becoming a loophole that delays proper full accountability


FluxKnight80

They learn, they adapt, they drift is such a precise way to describe why the old medical device framework genuinely doesn't fit here, a hip replacement doesn't quietly change its own behavior after approval the way an adaptive AI model can

PhotonBurst17

Patients having an explicit right to know when AI is involved in their care feels like the single most important recommendation on this whole list, that transparency is the foundation everything else, trust, accountability, actually depends on
Cashback on everything or it didn't happen

Dank

The L-plate system is a genuinely clever framing, borrowing a familiar concept from learner drivers to make supervised AI trials feel intuitive rather than abstract, though the actual supervision standards will matter enormously in practice

TransformerCipher

Curious how quickly any of these 44 recommendations actually become binding law versus staying advisory guidance, that gap between a regulator's recommendation and enforceable legislation can stretch on for years
Normal is overrated

Inference Scholar

Continuously monitoring and being willing to actually pull approval if an AI product drifts or malfunctions is the recommendation with the most real teeth here, ongoing accountability matters more than a one-time approval ever could for a system that keeps changing

MiniElliot

12,000 people including patients and clinicians contributing to this report gives it real grounded legitimacy, this isn't just regulators theorizing in isolation about what oversight should look like

Tundra

No country having fully cracked AI healthcare regulation yet is an honest admission worth appreciating, better to acknowledge that genuine global uncertainty than pretend the UK has found some definitive solution nobody else has

Related Topics (3)